$3.42
$0.00 (0.00%)
End-of-day quote: 08/11/2021
NasdaqCM:CBLI
Cleveland BioLabs Annual Report
Year | Year | 2021 | |
---|---|---|---|
Rev. | Revenue |
|
$0.00M |
GM % | Gross Margin % |
|
0.00% |
OM | Operating Margin |
|
0.00% |
EPS | Earnings Per Share |
|
$0.00 |
Div. | Dividends |
|
$0.00 |
PR % | Payout Ratio % |
|
0 |
Sha. | Shares |
|
0m |
OCF | Operating Cash Flow |
|
$0.00M |
FCF | Free Cash Flow |
|
$0.00M |
FCFS | Free Cash Flow Per Share |
|
$0.00 |